Fungal strains obtaining
Five hot local dermatophytes strains belong to the following species: Microsporum canis (M. canis), Microsporum gypseum (M. gypseum), Trichophyton equinum (T. equinum), Trichophyton verrucosum (T. verrucosum), and Trichophyton mentagrophytes (T. mentagrophytes), were used during the current study. The used strains were isolated, identified, and selected through a previous preliminary cross-sectional study on dermatological affections of companion animals caused by dermatophytes and other keratinophilic fungi in the Greater Cairo Area, Egypt, which has been conducted by the same scientific research team (Hassan AH, et al. 2021). Those strains have been used for the preparation of antigens that were used for immunization of animals during the lateral flow kit development stages, and also were used as a positive control during the newly developed kit validation stage.
Selection of dermatophyte strains
From the isolated dermatophyte species, the most suitable strains for vaccine production were selected according to the criteria reported by (Brandebusemeyer, et.al. 1990). According to these criteria, we found that dermatophyte vaccinal strain should be:
1- Local strain.
2- Isolated from badly infected cases.
3- Rapid grower in vitro.
4-Intensive spore formers, where the dermatophyte microconidia are considered as an important character for the selection of suitable vaccinal strain. This is because microconidia have been identified to be the carrier of immunogenicity.
5- High growth intensity that allows the production of a large number of fungal antigens.
Preparation of dermatophyte antigens (Hiroaki w and Masahiro M. 2016)
Mycelial matt antigens were prepared for each dermatophyte of the five species involved in the current study as follows; The isolated, identified, and selected strains have been cultured separately on non-supplemented Sabouraud’s dextrose broth, after 21 days, harvesting and separating of the superficial floating mycelial matt from the submerged soluble fungal structures using sterile gauze. Each harvested mycelial matt was homogenized using a homogenizer at 160 rpm for 5 minutes, then washed with sterile phosphate-buffered saline (PBS) three times, each time PBS suspension, centrifugation at 5000 rpm for 5 minutes, and discard of the supernatant were performed. Finally, each mycelial antigen was suspended in PBS to a concentration of 4%.
Preparation of emulsions used for animal immunization (Harold FS. 2005)
The immunization emulsion for dermatophytes mycelial antigen was prepared as follows; the priming immunization emulsion consisted of equal volumes of complete Freund’s adjuvant (Sigma-Aldrich®) and inactivated previously prepared 4% mycelial antigens, inactivation was performed using 0.5% formalin (Sigma-Aldrich®), mixed adequately using two syringes and connector for 20 minutes till reached a milky white viscous creamy emulsion stable after overnight testing at refrigerator temperature (6°C). The boostering immunization emulsion consisted of equal volumes of incomplete Freund’s adjuvant (Sigma-Aldrich®) and living previously prepared 4% mycelial antigens, mixed adequately using two syringes and connector for 20 minutes till reached a milky, white, viscous, and creamy emulsion with stable formulation after overnight testing at refrigerator temperature (6°C). Both types of immunization emulsions have been prepared and injected under aseptic techniques.
Lab animal selection and immunization protocol design
Two white male New-Zealand rabbits weighing 2 kg were designed to be used as the bio-factory for dermatophytes pAbs production. As using a fully mature animal will ensure a completely functioning immune system which is the cornerstone of antibody production. Also, rabbits were the chosen lab animal from the commonly used lab animal list used for antibody production as it is characterized by their small size, high affinity, relatively long life span, easy blood obtaining, strong immune response, and inexpensive housing. A number of two animals were injected with the same dermatophytes Ag to enlarge the obtained blood samples carrying antibodies for each Ag, also to take in advance the unexpected accidental death of one of the two animals before the end of the injection protocol.
Day 0 | A blood sample was collected from each animal involved in the conducted study |
Day 1 | 0.5ml/kg of the priming emulsion | The whole dose is injected intradermally (I/D) and divided into different 10 sites |
Day 14 | 1ml/kg of the boostering emulsion | The whole dose is injected subcutaneously (S/C) and divided into 5 different sites |
Day 28 | 1ml/kg of the boostering emulsion | The whole dose is injected S/C and divided into 5 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 38 | 1ml/kg of the boostering emulsion | The whole dose is injected S/C and divided into 5 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 48 | 1ml/kg of the boostering emulsion | The whole dose is injected S/C and divided into 5 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 55 | 1ml/kg of the boostering emulsion | Half of the dose S/C is divided into 2 different sites and the other half of I/M is divided into 2 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 62 | 1ml/kg of the boostering emulsion | Half of the dose is injected S/C and divided into 2 different sites and the other half is injected intramuscularly (I/M) and divided into 2 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 79 | 1ml/kg of the boostering emulsion | Half of the dose is injected S/C and divided into 2 different sites and the other half is injected I/M and divided into 2 different sites |
Ear vein blood samples collection and Agar gel precipitation tests were performed |
Day 90 | Final blood collection |
Table (1): Illustration of a detailed animal immunization schedule
Separation and purification of polyclonal antibodies (PAbs) (Federico P, et al. 1990)
The separately collected blood samples were kept for 1 hour undisturbed in a slightly oblique position at room temperature (25°C), followed by another hour in the refrigerator (6°C). Then 25ml of blood was centrifuged for 30 minutes at 10000 × g, the supernatant was collected, and the pellet was discarded. The obtained serum was placed on a magnetic stirrer, then dropwise of caprylic acid, 2.02 ml/25ml rabbit serum was dropped slowly while stirring at 25°C for 30 min. The mixtures were centrifuged at 10000 ×g for twenty min, the supernatants were collected, and the pellets were discarded. The collected supernatants were dialyzed separately against PBS at 4°C overnight using 12000–14000 molecular weight cut off (MOWC) dialysis bags (Sigma-Aldrich®) with three buffer changes, finally, the concentration of immunoglobulins was obtained by measuring both the total protein and the albumin concentrations of each obtained purified antibodies sample from the dialysis bags. The obtained immunoglobulins concentrations ranged from 1.1 to 1.4 g/dl. A 1 mg/ml concentration was then obtained using ultrapure water dilution. Furtherly, half the volume of the separately obtained dermatophytes species-specific polyclonal antibodies were pooled together in equal ratios to form a dermatophyte multispecies-specific polyclonal antibody (PAbs).
Agar gel precipitation test optimization for evaluating the separated PAbs (Rowa YA. 2018)
Agar gel plates were prepared as follows; 3mm agar gel thickness and 0.6% concentration were achieved by dissolving 0.6 g agarose in 100 ml PBS, then dissolved by boiling for 2 minutes and pouring 4ml from the preparation in 5 cm plates, then left to solidify. The agar gel test was used in several situations during the current study; First, to monitor the antibody production during the designed immunization protocol, second, to evaluate the consequence of the PAbs purification steps, third, to study the relationship between the produced species-specific PAbs and the prepared immunizing antigens, which derived from different dermatophyte species and the relationship between the produced dermatophyte multi-specific PAbs and other non-dermatophyte keratinophilic fungal antigens.
Preparation of colloidal gold (CG) nanoparticles (NPs) (Ying W, et al. 2014), (Lev D and Nicoli G. 2019), and (Petr S, et al. 2020)
50 ml of ultrapure water were placed on a hot plate till boiling (100°C), then vigorous magnetic stirring was started followed by the addition of 0.5ml of 0.2% HauCl4.3H2O (Gold III chloride trihydrate) (Sigma-Aldrich®). During the boiling of the mixture with vigorous stirring, 1 ml of 1% (w/v) sodium citrated buffer was added quickly. The color of the mixture began as a colorless solution changed to black then ruby red color (after approximately 2 minutes), then kept on stirring and at the boiling temperature (100°C) for another 10 min. The prepared nanoparticles were scanned at a range of 400–600 nm using a UV-Vis spectrophotometer and Transmissible electron microscope (TEM) imaging to determine their diameter. The obtained colloidal gold nanoparticles were confirmed to be 40 nm in diameter
Conjugation of the purified rabbit polyclonal antibodies with the colloidal gold nanoparticles (Au NPs-PAbs coupled bio-conjugate) (Constance O, 2010), (Mir HJ, et al. 2016), (Sadaki Y, 2016)
The performance of any newly developed lateral immunochromatography-based kit mainly depends on a variety of parameters, such as the antibody labeling by the gold nanoparticles, the pH value set within the strip microenvironment, and at which the Ag-Ab immune-complex is expected to occur if the target analyte exists, amount of specific antibodies required for optimal immunological coupling, and finally the antigen/antibody loading concentration of the test/control spots. Based on the colloidal gold preparation methodologies, the most stable and unaggregated immune-gold bio-conjugate is achievable at a pH that is slightly higher or near the isoelectric point of the conjugated protein. The highest adsorption capacity of antibodies on the surface of the gold nanoparticles was achieved by fixed unchanged ruby red color formed in the pH series between 7.2–7.6. 0.02 M potassium carbonate (K2CO3) was used to adjust the pH of colloidal gold to 7.4. The amount of antibodies that can form stable conjugates and optimally reacted test and control spots is another key factor for the success of the newly developed kit. To determine the optimal amount of antibodies, different concentrations of anti-dermatophytes IgG were tested. However, Au NP solution (100 µL) containing 1.0 µg of PAbs of anti-dermatophytes IgG on the conjugate pad could remain as stable ruby red reactions after exposure to the positive and negative control solutions. Half ml of purified multi-species rabbit PAbs (1 mg/ml) was added to 50 ml of colloidal gold nanoparticles. The solution was gently mixed for 10 minutes. Then centrifuged for 10 min at 10.000 × g, discarding the supernatant and keeping the pellet. The conjugated pellet was diluted in 1 ml conjugation dilution buffer, which was prepared as follows; 20 mM Tris, 0.02%(w/v) sodium azide, 3% (w/v) sucrose, and 1% (w/v) bovine serum albumin (BSA)) and stored in a refrigerator (6°C).
An overall newly developed kit fabrication and formulation procedures (Claudio P, et al. 2020)
Sample pad roll (Ahlstrom®)
pre-treated glass fiber with sample pad treatment solution pH 7.4 (ultra-pure water, 2% (w/v) triton X-100, 3.81% (w/v) Borax, 1% (w/v) Polyvinylpyrrolidone (PVP), 0.5%(w/v) sodium cholate, 0.15% (w/v) sodium dodecyl sulfate (SDS), 0.1% (w/v) casein sodium salt, 0.02% (w/v) sodium azide, then dried for 1hr at 37°C.
Conjugation pad roll (Ahlstrom®)
pre-treated glass fiber with conjugation treatment solution pH 7.4 (2.5% (w/v) sucrose, 20 mM PBS, 0.3%(w/v) PVP, 2% (w/v) BSA, 1% (w/v) triton X-100 and 0.02% (w/v) sodium azide).
Nitrocellulose membrane (NC) roll (Ahlstrom®): Microporous nitrocellulose membranes are used as the carrying matrix upon which Ag-Ab immunocomplexes are formed and visualized to indicate the presence or absence of the target analytic in liquid samples. Several reasons contributed to making NC the preferred LF solid phase: High affinity of protein adsorption, the chemical properties that led to stable protein adsorption levels in both dry and wet conditions of the NC membrane, and nitrocellulose membranes can be cast that have pores sufficiently large to allow a lateral flow of fluid in a reasonable time.
Absorbent (wick) pad roll (Ahlstrom®)
a cotton fiber pad roll, whose function is to collect the liquid processed through the strip by capillary action, offering consistent absorbency for test reproducibility, also allowing quick clearing of the membrane by absorbing higher volumes of liquid and access to the read-out in a shorter time.
Adhesive Polyvinyl chloride (PVC) sheets (Ahlstrom®)
A four-row laminated adhesive membrane as the carrier base of the rest components of the lateral flow strip, starting with removing the sticker from the second row and attaching the nitrocellulose membrane, followed by removing the sticker from the first row and attaching the absorbent pad, the third step was removing the sticker from the third row and attaching the conjugate pad, finally removing the sticker from the fourth row and attaching the sample pad which is diagrammatically illustrated in (Fig. 1).
Figure (1)
diagrammatic illustration of the main steps to build up the laminated lateral flow solid phase
Figure (2)
diagrammatic illustration of the building structures of each single lateral flow strip
To yield clear and accurate results, coating anti-dermatophytes PAbs and goat anti-rabbit IgG PAbs were optimized. The red on the C line was visible when the concentration of goat anti-rabbit IgG was more than 0.3 mg/mL and became clearest as the coating concentration increased to 0.5mg/ml. As for the T line, the color spot and uniform distribution were observed when the coating concentration was more than 0.5 mg/ml. To meet the requirements of the test strip observation, 1 mg/ml of anti-dermatophytes PAbs and 0.5 mg/ml of the polyclonal goat anti-rabbit IgG antibody (pH 7.4) were chosen as the optimal concentration. The antibody printer (IsoFlow®) was used to load the 0.5 µl of unlabeled goat anti-rabbit antibodies in the form of dots on the control spots, while the test spots were loaded as follows:
-
Single-plex edition: This is a single test spot dotted edition, which was developed in 6 versions; 1 dermatophyte multi-species version that was dotted with 1 µl of dermatophyte multi-species PAbs at the test spot and 5 dermatophytes species-specific versions dotted with 1 µl of dermatophyte species-specific PAbs at the test spot.
-
Multiplex edition: This is a multi-test spot dotted edition
The space between the test spot and control spot was adjusted to be 0.5 cm in the single-plex edition. The conjugate pad was loaded by impregnation in the conjugate solution achieving 5 µl conjugate on each cut conjugate pad of each strip.
The loaded adhered to the PVC card developed lateral flow sheets, automatically were cut by automatic Guillotine cutter achieving 0.4 cm width per strip, then due to the research level production quantity, manual assembly, and packaging of the strips into the lateral flow cartilage has occurred. The used cartilage is characterized by (S) letter labeled sample application window and (T and C) letter labeled window marking the test and control spots on the strip. The kit was assembled as a full set containing, the LFIA cartilage/cassette, scrapping brush, sample collection card, antigen extraction solution, and sample application pipette.
Preparation of antigen extraction solution
Due to the solid nature of the dermatological affection samples (hair, skin scraps, scales, nails), a “pre-application sample processing step” must be performed to extract the dermatophytes’ antigenic structures from the collected sample. Based on several laboratory-based trials and previously published literature (Hiroaki w and Masahiro M. 2016), (Noriki S. 2013), (Noriki S. 2015), (Higashi Y, et al. 2012), (Tsunemi Y, et al. 2014), (Tsunemi Y, et al. 2015) this solution was formulated and prepared as follows: 5 ml glycerin, 1ml propylene glycol, 1 g sodium dodecyl sulfate (SDS), 1 g dimethyl sulfoxide (DMSO), and 0.2 g Diazolidinyl urea were stirred and dissolved in 94 ml distilled water.
Collection of the samples used during the developed lateral flow testing and challenge with the wet mounts and cultures
A total of 100 samples (Skin scraps, scales, and hair) were collected from a wide range of companion animal species; Dogs, cats, horses, donkeys, cows, buffalos, rabbits, rats, and guinea pigs. All samples have been collected from animals suffering from dermatological affections and suspected by their clinician it would be a dermatophytes infection. All samples have been collected nearly by the same standardized sampling protocol by the hands of expert veterinarians and submitted either to LeptoVet® (an ISO 9001 accredited and licensed veterinary laboratory in Egypt) or to the mycology unit at the department of microbiology, faculty of veterinary medicine, Cairo University. These samples were directly tested through wet mounts and then confirmed as positive active dermatophytosis cases or negative cases by the gold standard selective dermatophytes culturing techniques (Hassan AH, et al. 2021).
Direct microscopic examination of the collected samples (Quinn, et al. 1990) and (Haldane DJ and Robart E. 1990)
Few hairs, and/or skin scraping were placed on a sterile slide. Few drops of potassium hydroxide (KOH) 10% with dimethyl sulfoxide (DMSO, Serva®) and glycerin (Serva®) were added to the sample (DMSO enhances KOH 10% clarifying ability, and glycerin as a source of humidity reducing the required incubation time). The slide was covered with a coverslip, heated gently, left in a humid chamber for 30 minutes, and examined using low and high dry power lenses of a bright-field microscope (Olympus CX31 microscope with camera model C-7070).
Culturing of the collected samples (Quinn, et al. 1990) and (Hassan AH, et al. 2021)
A total of 100 samples were examined by culturing on Sabouraud’s dextrose agar (SDA, Oxoid®) supplemented with 0.5 g/L chloramphenicol (Oxoid®) and 0.5 g/L cycloheximide (Oxoid®). Each sample was inoculated in 3 sets of supplemented SDA slopes and each set consisted of 3 slopes. The first set was only supplemented with the basic selective supplements (Chloramphenicol and cycloheximide) the second set was extra supplemented with specific supplements (thiamine (Serva®) and inositol (Serva®)) and the third set extra supplemented with different specific supplements, (Nicotinic acid (Serva®)). The first and third sets were incubated at 25°C and observed for up to 21 days while the second set was incubated at 30°C and observed for up to 30 days.
The newly developed kit testing procedures
Brushing the active peripheral border of the suspected lesion using the scrapping brush. The sample was collected in a black collection card to assess the amount of the collected sample. Then the sample was added to a 0.5 ml extraction solution with gentle mixing for 5 minutes at room temperature (25°C). 100 µl (3 drops) of the extracted antigen was applied to the sample application window using the application pipette. The presence of dermatophyte antigens was detected by the appearance of a specific color tracer of Au NPs.
Figure (3)
the newly developed Dermato-kit components